The panel discussion at the Current Trends in Biotherapeutics Workshop was called “If You Build It, Will They Fund It?” It was moderated by Ella Korets-Smith, Chief Business Officer, Virica Biotech.
The panel included:
– Michael Israels, Chief Financial Officer, CCRM
– David O’Neill, PhD, President, FACIT
– Eli Berenbeim, MBA, Director, Creative Destruction Lab (West)
– Alexandre Le Bouthillier, PhD, Co-Founder, Imagia
The Clinical Translation Education Group, composed of BioCanRx, CCRM, CellCAN, Ontario Institute for Cancer Research (OICR), Ontario Institute for Regenerative Medicine (OIRM) and Stem Cell Network, hosted a one-day workshop on current trends and innovations in cell and gene therapy with an emphasis on disruptive technologies. The session introduced new tools and strategies that are shaping where the biotherapeutic field is headed. The workshop took place in Toronto on September 27, 2019.
For information about future CTEG training and education events, visit the Events page on ccrm.ca.
